Diabetes Drugs Market Research Reports
Title | published | price | |
---|---|---|---|
Global Insulin Glargine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028By Maia Research "...... n 2028, with a CAGR of 6.82% during the forecast years.
Insulin glargine, marketed under the names Lantus among others, is a long-acting insulin, used in the treatment of type I and type II diabetes.
This report covers a ......" | 19-Dec-2023 | $3380 | |
Global Glucagon Market Research Report 2024 (Status and Outlook)By Bosson Research "...... a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bl......" | 15-Dec-2023 | $3200 | |
Global Insulin Glargine Market Research Report 2024 (Status and Outlook)By Bosson Research "...... 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).
The Global Insulin Glargine Market Size was estimated at USD 8856.10 million in 2022 and is projected to reach USD 11654.02 million by 2029, exhibiti......" | 15-Dec-2023 | $3200 | |
Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2024 (Status and Outlook)By Bosson Research "...... projected to reach USD 10600.27 million by 2029, exhibiting a CAGR of 2.30% during the forecast period.
This report provides a deep insight into the global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market covering all its essential aspects. Th......" | 15-Dec-2023 | $3200 | |
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2024 (Status and Outlook)By Bosson Research "...... causing hypoglycemia.
The Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size was estimated at USD 8816.20 million in 2022 and is projected to reach USD 21129.58 million by 2029, exhibiting a CAGR of 13.30% during the forecast period. ......" | 15-Dec-2023 | $3200 | |
Global Lixisenatide Market Research Report 2023By QYResearch Group "...... any
- Zealand Pharma
- Sanofi-Aventis
Segment by Type
- Tablet
- Liquid Injection
Segment by Application
- Hospital
- Clinic
- Medical center
- Others
Cons......" | 14-Dec-2023 | $2900 | |
Global Incretin-Based Drugs Market Research Report 2023By QYResearch Group "...... >By Company
- GlaxoSmithKline
- Johnson & Johnson
- Merck & Co
- AstraZeneca
- Novartis
- Eli Lilly and Company
- Boehringer Ingelheim
- Takeda Pharmaceutical Company
- Sanofi
......" | 14-Dec-2023 | $2900 | |
Global Glimepiride Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028By Maia Research "...... % during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Glimepiride market, with a systematical description of the status quo and trends of the......" | 05-Dec-2023 | $3380 | |
Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)By Azoth Analytics "...... Dipeptidyl Peptidase-4 Inhibitors), By Route of Administration (Oral, Injectables) and By Indication (Diabetes, Obesity) for the historical period of 2018-2022, the estimated year of 2023 and the forecast period of 2024-2028.
The rese......" | 01-Dec-2023 | $2450 | |
Global Insulin Lispro Professional Survey Report 2023, Forecast to 2028By Multimarket Insight "...... SD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to dem......" | 27-Nov-2023 | $3280 | |
|